HyEnergy Spolka Akcyjna
GGPW:HEN2.32
PLN
0.00
(0.00%)
ISIN
PLINNGN00015
Return %
Stock
S&P 500
1Y
0.00
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Jacek Wojciechowicz
- Sector
- Commercial services
- Industry
- Miscellaneous commercial services
- Address
- Warsaw Poland
- IPO Date
- Feb 8, 2011
- Similar Companies
- Business
- HyEnergy Spolka Akcyjna is a Polish clean technology and life sciences enterprise that develops green hydrogen generation infrastructure, synthetic clean fuels, and advanced molecular diagnostic solutions. Founded in 2010 and headquartered in Warsaw, Poland, the company is publicly traded on the Warsaw Stock Exchange NewConnect market under the ticker symbol GPW:HEN. The company operates across two principal business divisions: Clean Energy and Molecular Diagnostics. In its Clean Energy segment, operating primarily through its subsidiary Hydrogenium P.S.A., the company provides plasma-assisted biomass gasification systems for the production of green hydrogen, syngas, and biogenic carbon dioxide; synthetic chemical fuels including e-methanol, green ammonia, and biomass-to-liquid hydrocarbons; proprietary Hydrogen-as-a-Service delivery models encompassing equipment sales, plant engineering, and modular installation leasing for industrial facilities; and intellectual property licensing for thermochemical waste-to-energy conversion systems. In its Molecular Diagnostics segment, operating through its subsidiary Centrum Badan DNA Sp. z o.o., the company offers next-generation sequencing and genetic testing panels for oncological, cardiovascular, metabolic, and hereditary disorders; contract research and development services for pharmaceutical and academic institutions; custom molecular assay development; and clinical genomic biobanking services. HyEnergy Spolka Akcyjna serves chemical producers, energy utilities, industrial manufacturers, healthcare providers, research institutes, and clinical laboratories across Poland, Central Europe, and North America through affiliates including HiEnergy Canada. In recent major corporate developments, the company rebranded from INNO-GENE S.A. to HyEnergy Spolka Akcyjna in early 2025 to reflect a comprehensive strategic pivot into the zero-emission hydrogen economy. As part of this reorganization, the group completed the majority acquisition of Hydrogenium P.S.A. to integrate proprietary plasma gasification intellectual property, rolled out a 2025–2028 strategic development program focused on deploying commercial green hydrogen and e-methanol production facilities via dedicated special purpose vehicles, initiated expansion into new international markets, and structured efforts to secure strategic equity partners for its diagnostics unit to accelerate capital deployment into scalable clean energy assets.